Greater improvements of liver histology, as well as reductions of oxidative stress and plasma levels of inflammation markers, including C-reactive protein (CRP), TNF-α, and interleukine-6 (IL-6) were also seen in T2D rats treated for two weeks with a combination of metformin and atorvastatin when compared to metformin monotherapy [10]. Here, IL6 is linked to type 2 diabetes mellitus.